Xueying Cao

Novartis (Switzerland)

Papers

1

Total Citations

40

H-Index

1

About

Xueying Cao is a leading researcher in ion channel biophysics and drug discovery, with a particular focus on advancing high-throughput electrophysiology. Her most cited work, "IonFlux: A Microfluidic Patch Clamp System Evaluated with Human Ether-à-go-go Related Gene Channel Physiology and Pharmacology" (2011, 40 citations), introduced a transformative microfluidic patch clamp platform that significantly improved the throughput and predictive accuracy of ion channel assays. This innovation addressed a critical bottleneck in pharmaceutical development, enabling more efficient screening of compounds for both therapeutic efficacy and cardiotoxicity risks, particularly for the hERG channel—a key target in safety pharmacology. Cao’s contributions have directly enhanced the cost-effectiveness and reliability of preclinical drug testing, bridging the gap between traditional manual patch clamping and the demands of modern drug discovery pipelines. Her work is widely cited by researchers in electrophysiology, microfluidics, and cardiovascular safety, underscoring its lasting impact on both academic research and industrial applications.

Research Focus

Key Achievements

1
H-Index
1
Papers
40
Total Citations
40
Avg Citations/Paper
🏆 Most Cited Paper
IonFlux: A Microfluidic Patch Clamp System Evaluated with Human <i>Ether-à-go-go</i> Related Gene Channel Physiology and Pharmacology
40 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Novartis (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago